# Biomarker Development in LGMD2i

> **NCT04202627** · — · COMPLETED · sponsor: **ML Bio Solutions, Inc.** · enrollment: 101 (actual)

## Conditions studied

- Muscular Dystrophies
- Limb Girdle Muscular Dystrophy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04202627
- **Lead sponsor:** ML Bio Solutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-01
- **Primary completion:** 2022-10-10
- **Final completion:** 2022-10-10
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2023-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04202627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04202627, "Biomarker Development in LGMD2i". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04202627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*